GB0029920D0 - Use of glp-1 and glp-2 peptides - Google Patents

Use of glp-1 and glp-2 peptides

Info

Publication number
GB0029920D0
GB0029920D0 GB0029920A GB0029920A GB0029920D0 GB 0029920 D0 GB0029920 D0 GB 0029920D0 GB 0029920 A GB0029920 A GB 0029920A GB 0029920 A GB0029920 A GB 0029920A GB 0029920 D0 GB0029920 D0 GB 0029920D0
Authority
GB
United Kingdom
Prior art keywords
glp
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0029920A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunodiagnostic Systems Nordic AS
Original Assignee
Osteometer Biotech AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteometer Biotech AS filed Critical Osteometer Biotech AS
Priority to GB0029920A priority Critical patent/GB0029920D0/en
Publication of GB0029920D0 publication Critical patent/GB0029920D0/en
Priority to PCT/EP2001/010714 priority patent/WO2002022151A2/en
Priority to AT01982302T priority patent/ATE396738T1/en
Priority to PT01982302T priority patent/PT1326630E/en
Priority to ES01982302T priority patent/ES2310192T3/en
Priority to EP01982302A priority patent/EP1326630B1/en
Priority to US09/954,304 priority patent/US6770620B2/en
Priority to AU2002213925A priority patent/AU2002213925A1/en
Priority to DE60134251T priority patent/DE60134251D1/en
Priority to JP2002526401A priority patent/JP5161412B2/en
Priority to EP08156283A priority patent/EP1970072A1/en
Priority to DK01982302T priority patent/DK1326630T3/en
Priority to JP2002528284A priority patent/JP5189723B2/en
Priority to AU2001287892A priority patent/AU2001287892A1/en
Priority to PT01967517T priority patent/PT1414486E/en
Priority to EP01967517A priority patent/EP1414486B1/en
Priority to PCT/GB2001/004178 priority patent/WO2002024214A2/en
Priority to ES01967517T priority patent/ES2345874T3/en
Priority to DE60142084T priority patent/DE60142084D1/en
Priority to DK01967517.2T priority patent/DK1414486T3/en
Priority to AT01967517T priority patent/ATE466592T1/en
Priority to US10/391,460 priority patent/US6943151B2/en
Priority to US10/393,524 priority patent/US7186683B2/en
Priority to US11/035,826 priority patent/US7371721B2/en
Priority to US11/603,793 priority patent/US20070135345A1/en
Priority to US12/082,277 priority patent/US20080249016A1/en
Priority to CY20081100866T priority patent/CY1108263T1/en
Priority to CY20101100721T priority patent/CY1110721T1/en
Ceased legal-status Critical Current

Links

GB0029920A 2000-09-18 2000-12-07 Use of glp-1 and glp-2 peptides Ceased GB0029920D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GB0029920A GB0029920D0 (en) 2000-12-07 2000-12-07 Use of glp-1 and glp-2 peptides
DK01982302T DK1326630T3 (en) 2000-09-18 2001-09-17 Use of GLP-2 peptides
ES01982302T ES2310192T3 (en) 2000-09-18 2001-09-17 USE OF GLP-2 PEPTIDES.
AT01982302T ATE396738T1 (en) 2000-09-18 2001-09-17 USE OF GLP-2 PEPTIDES
PT01982302T PT1326630E (en) 2000-09-18 2001-09-17 Use of glp-2 peptides
PCT/EP2001/010714 WO2002022151A2 (en) 2000-09-18 2001-09-17 Use of glp-1 and flp-2 peptides for treatment of bone disorders
EP01982302A EP1326630B1 (en) 2000-09-18 2001-09-17 Use of glp-2 peptides
US09/954,304 US6770620B2 (en) 2000-09-18 2001-09-17 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
AU2002213925A AU2002213925A1 (en) 2000-09-18 2001-09-17 Use of glp-1 and flp-2 peptides for treatment of bone disorders
DE60134251T DE60134251D1 (en) 2000-09-18 2001-09-17 USE OF GLP-2 PEPTIDES
JP2002526401A JP5161412B2 (en) 2000-09-18 2001-09-17 Methods of using GLP-1 and GLP-2 peptides
EP08156283A EP1970072A1 (en) 2000-09-18 2001-09-17 Use of GLP-2 peptides for the treatment of hyperparathyroidism
AU2001287892A AU2001287892A1 (en) 2000-09-18 2001-09-18 Use of glp -2 in combination with another therapeutic agent in bone-related and nutrition-related disorders
JP2002528284A JP5189723B2 (en) 2000-09-18 2001-09-18 Methods of using GLP for the treatment, prevention, diagnosis and prognosis of bone and nutrition related diseases
AT01967517T ATE466592T1 (en) 2000-09-18 2001-09-18 USE OF GLP-2 IN CONJUNCTION WITH ANOTHER THERAPEUTIC AGENT IN BONE DISEASES
PT01967517T PT1414486E (en) 2000-09-18 2001-09-18 Use of glp-2 in combination with another therapeutic agent in bone-related disorders
EP01967517A EP1414486B1 (en) 2000-09-18 2001-09-18 Use of glp-2 in combination with another therapeutic agent in bone-related disorders
PCT/GB2001/004178 WO2002024214A2 (en) 2000-09-18 2001-09-18 Use of glp -2 in combination with another therapeutic agent in bone-related and nutrition-related disorders
ES01967517T ES2345874T3 (en) 2000-09-18 2001-09-18 USE OF GLP-2 IN COMBINATION WITH ANOTHER THERAPEUTIC AGENT IN BONE-RELATED PROBLEMS.
DE60142084T DE60142084D1 (en) 2000-09-18 2001-09-18 USE OF GLP-2 IN CONNECTION WITH ANOTHER THERAPEUTIC AGENT IN BONE DISEASES
DK01967517.2T DK1414486T3 (en) 2000-09-18 2001-09-18 Use of GLP-2 in combination with another therapeutic agent in bone-related diseases
US10/391,460 US6943151B2 (en) 2000-09-18 2003-03-18 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds
US10/393,524 US7186683B2 (en) 2000-09-18 2003-03-20 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
US11/035,826 US7371721B2 (en) 2000-09-18 2005-01-14 Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
US11/603,793 US20070135345A1 (en) 2000-09-18 2006-11-22 Use of GLP-2 for the treatment or prevention, of bone-related disorders
US12/082,277 US20080249016A1 (en) 2000-09-18 2008-04-09 Use of GLP-2 in a combination treatment for bone-related disorders
CY20081100866T CY1108263T1 (en) 2000-09-18 2008-08-13 USE OF GLP-2 PELLETS
CY20101100721T CY1110721T1 (en) 2000-09-18 2010-07-30 Use GLP-2 in combination with other therapeutic agents in bone diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0029920A GB0029920D0 (en) 2000-12-07 2000-12-07 Use of glp-1 and glp-2 peptides

Publications (1)

Publication Number Publication Date
GB0029920D0 true GB0029920D0 (en) 2001-01-24

Family

ID=9904671

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0029920A Ceased GB0029920D0 (en) 2000-09-18 2000-12-07 Use of glp-1 and glp-2 peptides

Country Status (1)

Country Link
GB (1) GB0029920D0 (en)

Similar Documents

Publication Publication Date Title
AU8079901A (en) Promyostatin peptides and methods of using same
EP1448222A4 (en) Biphasic mixtures of glp-1 and insulin
AU6723401A (en) Antimicrobial peptides and methods of use thereof
AU2002230953A1 (en) Recombinant phytases and uses thereof
SI1462455T1 (en) Ser-Ser-Ser-Arg peptide and medicinal uses thereof
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
GB0026134D0 (en) Peptides and their use
EP1308509A4 (en) Novel physiologically active peptide and use thereof
GB0014128D0 (en) Composite material and use therof
GB0029920D0 (en) Use of glp-1 and glp-2 peptides
GB0022844D0 (en) Use of GLP-1 and GLP-2 peptides
EP1357129A4 (en) Novel physiologically active peptide and use thereof
EP1337543A4 (en) Streptavidin-binding peptides and uses thereof
GB0018887D0 (en) Compound and their therapeutic use
GB2364764B (en) Hand and wrist support
GB2347612B (en) Wrist and hand support
EP1275659A4 (en) Novel physiologically active peptides and use thereof
PL357906A1 (en) Combination of carboxyalkylethers with antihypertensives and pharmaceutical use
GB0017028D0 (en) Peptides and their therapeutic use
AU5104101A (en) Composition and use
GB2363981B (en) Assemblies of Case-holder and Case
EP1395276A4 (en) Structurally modified peptides and uses thereof
IL145527A0 (en) Retro-inverso prosaposin-derived peptides and use thereof
GB0018148D0 (en) Peptides and their use
GB0026136D0 (en) Peptides and their use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)